InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-10 · accession 0001179110-22-001094 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-02-11 2022-02-10 PTCT Boulding Mark Elliott EVP, CLO S - Sale+OE $45.03 -17.9K 61.1K -23% -$807.6K
DM 2022-02-11 2022-02-10 PTCT Boulding Mark Elliott EVP, CLO M - OptEx $17.15 +17.9K 63.4K +39% +$307.5K
DM 2022-02-11 2022-02-10 PTCT Boulding Mark Elliott EVP, CLO M - OptEx $17.15 -17.9K 0 -100% -$307.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-10 S D 15,653 $45.03 61,110 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.01 to $45.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2022-02-10 M A 15,653 $18.01 76,763 D — —
3 Common Common Stock 2022-02-10 M A 2,282 $11.23 63,392 D — —
4 Common Common Stock 2022-02-10 S D 2,282 $45.03 61,110 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.01 to $45.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (Right to Buy) 2022-02-10 M D 2,282 $11.23 2,281 D $11.23 · — to 2027-01-02 2,282 Common Stock (F3) Currently exercisable.
6 Derivative Stock Option (Right to Buy) 2022-02-10 M D 15,653 $18.01 0 D $18.01 · — to 2028-01-02 15,653 Common Stock (F3) Currently exercisable.